Table: Immuno Biological Lab -2020/21 group results

Immuno-Biological Laboratories

14/05/2021 08:00

May 14 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2021    Mar 31, 2020    Mar 31, 2022      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          602 mln         576 mln         770 mln                 
               (+4.5 pct)      (-26.2 pct)     (+27.7 pct)               
  Operating   loss 240 mln    loss 595 mln    loss 107 mln               
  Recurring   loss 310 mln    loss 678 mln    loss 154 mln               
  Net
  Net         loss 318 mln    loss 668 mln    loss 162 mln               
  EPS        loss 34.23 yen  loss 76.00 yen  loss 17.42 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T